UroGen Pharma Ltd. (URGN) › Shares OutstandingUroGen Pharma Ltd. (URGN) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2016: 2.31M2017: 13.75M2018: 16.21M2019: 21.03M2020: 22.17M2021: 22.46M2022: 23.13M2023: 32.49M2024: 42.23M2025: 48.35M48.35M2016Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY202548.35M+14.5%202442.23M+30.0%202332.49M+40.5%202223.13M+3.0%202122.46M+1.3%202022.17M+5.4%201921.03M+29.7%201816.21M+17.9%201713.75M+496.4%20162.31M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share